TSC1 and tuberous sclerosis: TSC are characterized by TSC1 or TSC2 mutations, which are responsible for the overactivation of the mTOR signaling pathway, leading to aberrant cell development [106] TSC may manifest with 3 principal intracranial pathological entities: cortical tubers, subependymal nodules (SENs), and SEGAs.